StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.77−0.07 (-2.46%)

Close on Nov 18, 2026Market cap $546.32MP/E –Yield –

Wave Life Sciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Wave Life Sciences's market cap was $661.01M on Nov 11, 2026, against $1.49B a year earlier. Over the last 5 years it ranged from $85.20M to $2.72B, with a median of $607.89M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$661.01M-75.7%
2025Dec 31, 2025$2.72B+48.4%
2024Dec 31, 2024$1.84B+267.1%
2023Dec 29, 2023$500.01M-17.7%
2022Dec 30, 2022$607.89M+272.3%
2021Dec 31, 2021$163.27M-57.5%
2020Dec 31, 2020$383.81M+39.7%
2019Dec 31, 2019$274.79M-77.8%
2018Dec 31, 2018$1.24B+26.9%
2017Dec 29, 2017$974.65M+58.8%
2016Dec 30, 2016$613.85M+317.3%
2015Dec 31, 2015$147.11M–

More Wave Life Sciences figures

See a number that looks wrong?